Figure 2
Enhanced CD8
+ T cell activation in vivo by Δ
secA2.
(A) Mice were infected i.v. with the indicated bacterial strains, and spleens were harvested after 7 days for quantitation of SIINFEKL-specific T cells by IFN-γ ELISPOT. SFC, spot-forming cells. (B) CTL activity was measured in vivo by transfer of a mixture of SIINFEKL-pulsed CFSElow and unpulsed CFSEhigh splenocytes into recipient mice 14 days after infection with the indicated bacteria. Relative proportions of CFSElow and CFSEhigh were quantitated by FACS to determine percent specific lysis. (C) CD4+ T cell responses were unaffected by deletion of secA2. Seven days after infection with indicated bacteria, responses of splenocytes to purified protein derivative (PPD) and peptide-25 (Pep25) were determined by ELISPOT. (D) Thy1.1+ B6.PL mice were injected with CFSE-labeled Thy1.2+ OT-I splenocytes, and infected with the indicated bacteria. CD8+ T cell activation was assessed 6 days after infection by CFSE dilution. Dot plots show representative mice, and bar graphs show means and SDs for percentages of undivided cells in the transferred population for 2 or 3 mice per bacterial strain. (E) The enhanced CD8+ T cell proliferation induced by ΔsecA2 was reversed by reexpression of SodA secretion in the ΔsecA2-αsodA strain. Dot plots show CFSE dilution in the transferred population 6 days after infection with the indicated strains. The bar graph on the right shows means and SDs of the percentages of undivided cells for groups of 4 mice infected with each bacterial strain. All results are representative of at least 2 independent experiments.